After starting the initial 0.25 mg dose in the first week, most patients will experience some mild gastrointestinal side effects, such as nausea or abdominal discomfort, as their body adjusts to the medication
Theyve helped many people lose significant weight
2009 Jun;11(6):623-31
According to Elevate Health's terms, these are licensed US 503a compounding pharmacies that dispense medications according to the prescriptions they receive
The FDA has approved several GLP-1 medications including liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), semaglutide (Ozempic, Wegovy, Rybelsus), and tirzepatide (Mounjaro, Zepbound)though tirzepatide is technically a dual GIP/GLP-1 receptor agonist
We recorded the weight of mice since the beginning of the experiment and the differences in the last weight of each group